Unexpected discovery points to a possible route for childhood brain tumor treatments

When researchers at Lund College investigated how the molecule UM171 works, a molecule used to make blood stem cells multiply, they made an surprising connection. The outcomes present new insights into how one of the vital widespread malignant mind tumors in kids could possibly be handled sooner or later. 

UM171 is an artificial molecule developed by researchers at Université de Montréal. In stem cell analysis, it’s used to extend the variety of blood stem cells exterior the physique. The molecule helps cells retain their stem cell properties relatively than mature into blood cells and stimulates their multiplication. The purpose is to supply sufficient stem cells for transplantation in sufferers with critical blood ailments. Lately, researchers, together with these at Lund College, have proven that the molecule works by exploiting a protein known as KBTBD4. This causes an vital protein construction within the cell, known as CoREST, to interrupt down.

The identical construction within the cell can also be affected by mutations within the KBTBD4 gene, genetic modifications that happen in a subgroup of aggressive mind tumors in kids. Though the causes differ, the outcome is similar – the construction breaks down.”

Agatheeswaran Subramaniam, researcher, Lund College

Medulloblastoma is the most typical malignant mind tumor in kids and impacts round 15–20 kids in Sweden annually. The tumor belongs to the group of embryonal mind tumors, that are thought to come up when immature cells within the growing mind don’t mature as they need to however proceed to divide. Some circumstances of medulloblastoma are linked to mutations in KBTBD4. These tumors are very troublesome to recreate within the laboratory as a result of they come up early throughout mind improvement.

“It’s hanging {that a} small molecule and genetic mutations result in the identical impact within the cell. However whereas the molecule has a short lived impact, the mutations as a substitute result in a long-term scarcity of CoREST, that means that the cells stay in a stem cell-like state. This may occasionally contribute to the event of embryonal tumors,” says Rohit Sivaprasad, doctoral pupil at Lund College.

The researchers additionally carried out a large-scale drug display screen and located that HDAC inhibitors counteract the consequences of KBTBD4 mutations. HDAC inhibitors are a kind of drug that impacts gene exercise in cells. The examine is an instance of so-called drug repurposing, the place an already authorised drug is given a brand new use in one other illness space. The findings present new information about how these mind tumors come up and level to a doable route in direction of future remedies.

“What’s fascinating about analysis is that generally you discover a basic mechanism that may assist reply a number of totally different scientific questions. This examine was carried out within the laboratory utilizing blood stem cells. The following step is to check whether or not these medication work in medulloblastoma tumors,” concludes Agatheeswaran Subramaniam.